Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U01IP001091 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centers for Disease Control and Prevention | FED |
Not provided
Not provided
Not provided
Not provided
The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.
Boot Camp Translation (BCT) is a process to identify strategies that help communities improve health. It is a 6-month, facilitated, iterative community engagement process that brings together relevant stakeholders to develop and implement locally meaningful messages, materials, and strategies for health topics of interest.
This is a novel community engagement process that has a proven ability to result in meaningful and impactful strategies to improve compliance with recommended health behaviors in rural communities. The investigators will expand this work by testing BCT on its ability to improve vaccination with all recommend adolescent vaccines (Tdap, MenACWY, HPV, Flu).
The investigators will conduct a randomized, controlled trial in which 4 rural communities in Western Colorado will undergo BCT to develop and implement strategies to increase adolescent vaccination. Vaccination rates will be compared to 4 control communities that do not undergo BCT.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Boot Camp Translation | Experimental | Intervention communities will undergo the Boot Camp Translation process. |
|
| Control | Active Comparator | Control communities will behave as usual |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Boot Camp Translation | Behavioral | Communities in the intervention arm will participate in the Boot Camp translation process, where stakeholders will come together to develop and implement locally relevant materials to promote adolescent vaccination. |
| Measure | Description | Time Frame |
|---|---|---|
| Initiation of HPV vaccination series, 11-12 year olds | Percent of 11-12 year olds who have received >=1 dose of the HPV vaccine by May 31,2021 | Up to 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Completion of HPV vaccination series, 11-12 year olds | Percent of 11-12 year olds with >=2 doses of the HPV vaccine by May 31,2021 | Up to 24 months |
| Initiation of HPV vaccination series, 13-17 year olds |
| Measure | Description | Time Frame |
|---|---|---|
| Receipt of influenza vaccine | Percent of 11-17 year olds who receive the influenza vaccine between Sept 2020 and May 2021 | Up to 24 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sean T O'Leary, MD | University of Colorado, Denver | Principal Investigator |
| Amanda Dempsey, MD, PhD, MPH | University of Colorado, Denver | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38253469 | Derived | Cataldi JR, Suresh K, Brewer SE, Perreira C, Nederveld A, Skenadore A, Furniss A, Williams C, Severson R, Dempsey AF, O'Leary ST. Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial. Vaccine. 2024 Feb 15;42(5):1078-1086. doi: 10.1016/j.vaccine.2024.01.042. Epub 2024 Jan 21. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study team data analyst will be provided with blinded data.
| Control | Other | No intervention. Communities will continue to behave as usual. |
|
Percent of 13-17 year olds who have received >=1 dose of the HPV vaccine by May 31,2021
| Up to 24 months |
| Completion of HPV vaccination series, 13-17 year olds | Percent of 13-17 year olds who have completed the HPV vaccine series (2 or 3 doses, depending on age of initiation) by May 31,2021 | Up to 24 months |
| Receipt of Tdap vaccine, 11-12 year olds | Percent of 11-12 year olds who have received Tdap vaccine by May 31,2021 | Up to 24 months |
| Receipt of Tdap vaccine, 13-17 year olds | Percent of 13-17 year olds who have received Tdap vaccine by May 31,2021 | Up to 24 months |
| Receipt of MCV vaccine, 11-12 year olds | Percent of 11-12 year olds who have received >=1 dose of MCV vaccine by May 31,2021 | Up to 24 months |
| Receipt of MCV vaccine, 13-17 year olds | Percent of 13-17 year olds who have received >=1 dose of MCV vaccine by May 31,2021 | Up to 24 months |